Could new scans revolutionize nasopharyngeal cancer care?

NCT ID NCT07137052

First seen Jun 26, 2026 ยท Last updated Jun 26, 2026

Summary

This observational study will test whether two new types of PET/CT scans can more accurately stage nasopharyngeal carcinoma and predict how well patients respond to immunotherapy before treatment. About 732 participants aged 18-70 with newly diagnosed, untreated cancer will receive the scans. The goal is to see if these imaging techniques improve staging accuracy and early prediction of treatment success.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
Gallium-68 labeled tracers (68Ga-FAPI-LM3 and 68Ga-PD-L1) for PET/CT imaging
What this could lead to
If successful, this could lead to more accurate staging and earlier prediction of how well immunotherapy works for nasopharyngeal carcinoma, helping doctors tailor treatments.
What could go wrong
This is an observational study, not a treatment trial, so it won't directly improve outcomes. The imaging techniques are still experimental and may not prove better than current methods.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NASOPHARYNGEAL CARCINOMA (NPC) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

More trials for these conditions

Other studies related to the condition(s) this trial covers.